Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor

Parkinsonism Relat Disord. 2010 Feb;16(2):112-4. doi: 10.1016/j.parkreldis.2009.08.011. Epub 2009 Sep 20.

Abstract

A functional variant in the Histamine N-Methyltransferase gene (HNMT - rs11558538) resulting in a threonine to isoleucine substitution (Thr105Ile) has been shown to impair histamine degradation. Two recent studies reported that the threonine allele of this polymorphism might be a risk factor for Parkinson disease (PD) and essential tremor (ET) development. Although PD and ET are considered different entities, they share some clinical and pathological features, suggesting a possible joint etiology. In this study we assess the role of the Thr105Ile variant in PD and ET development, genotyping the variant in a North American Caucasian PD and ET case-control series. Statistical analysis did not identify any significant association between this variant and PD or ET; therefore, our findings do not support the HNMT Thr105Ile variant as a factor in disease development or a genetic link between the disorders.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Essential Tremor / genetics*
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Genotype
  • Histamine N-Methyltransferase / genetics*
  • Humans
  • Isoleucine / genetics*
  • Male
  • Middle Aged
  • Parkinson Disease / genetics*
  • Polymorphism, Genetic / genetics*
  • Psychiatric Status Rating Scales
  • Threonine / genetics*

Substances

  • Isoleucine
  • Threonine
  • Histamine N-Methyltransferase